-
Je něco špatně v tomto záznamu ?
Current Aspects of the Role of Autoantibodies Directed Against Appetite-Regulating Hormones and the Gut Microbiome in Eating Disorders
K. Smitka, P. Prochazkova, R. Roubalova, J. Dvorak, H. Papezova, M. Hill, J. Pokorny, O. Kittnar, M. Bilej, H. Tlaskalova-Hogenova
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- MeSH
- autoprotilátky * MeSH
- ghrelin imunologie MeSH
- inzulin imunologie MeSH
- leptin imunologie MeSH
- lidé MeSH
- melanocyty stimulující hormony imunologie MeSH
- neuropeptid Y imunologie MeSH
- poruchy příjmu potravy imunologie mikrobiologie MeSH
- střevní mikroflóra imunologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The equilibrium and reciprocal actions among appetite-stimulating (orexigenic) and appetite-suppressing (anorexigenic) signals synthesized in the gut, brain, microbiome and adipose tissue (AT), seems to play a pivotal role in the regulation of food intake and feeding behavior, anxiety, and depression. A dysregulation of mechanisms controlling the energy balance may result in eating disorders such as anorexia nervosa (AN) and bulimia nervosa (BN). AN is a psychiatric disease defined by chronic self-induced extreme dietary restriction leading to an extremely low body weight and adiposity. BN is defined as out-of-control binge eating, which is compensated by self-induced vomiting, fasting, or excessive exercise. Certain gut microbiota-related compounds, like bacterial chaperone protein Escherichia coli caseinolytic protease B (ClpB) and food-derived antigens were recently described to trigger the production of autoantibodies cross-reacting with appetite-regulating hormones and neurotransmitters. Gut microbiome may be a potential manipulator for AT and energy homeostasis. Thus, the regulation of appetite, emotion, mood, and nutritional status is also under the control of neuroimmunoendocrine mechanisms by secretion of autoantibodies directed against neuropeptides, neuroactive metabolites, and peptides. In AN and BN, altered cholinergic, dopaminergic, adrenergic, and serotonergic relays may lead to abnormal AT, gut, and brain hormone secretion. The present review summarizes updated knowledge regarding the gut dysbiosis, gut-barrier permeability, short-chain fatty acids (SCFA), fecal microbial transplantation (FMT), blood-brain barrier permeability, and autoantibodies within the ghrelin and melanocortin systems in eating disorders. We expect that the new knowledge may be used for the development of a novel preventive and therapeutic approach for treatment of AN and BN.
1st Faculty of Medicine Institute of Pathological Physiology Charles University Prague Czechia
1st Faculty of Medicine Institute of Physiology Charles University Prague Czechia
Steroid Hormone and Proteofactors Department Institute of Endocrinology Prague Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004444
- 003
- CZ-PrNML
- 005
- 20220127145232.0
- 007
- ta
- 008
- 220113s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fendo.2021.613983 $2 doi
- 035 __
- $a (PubMed)33953692
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Smitka, Kvido $u First Faculty of Medicine, Institute of Physiology, Charles University, Prague, Czechia $u First Faculty of Medicine, Institute of Pathological Physiology, Charles University, Prague, Czechia
- 245 10
- $a Current Aspects of the Role of Autoantibodies Directed Against Appetite-Regulating Hormones and the Gut Microbiome in Eating Disorders / $c K. Smitka, P. Prochazkova, R. Roubalova, J. Dvorak, H. Papezova, M. Hill, J. Pokorny, O. Kittnar, M. Bilej, H. Tlaskalova-Hogenova
- 520 9_
- $a The equilibrium and reciprocal actions among appetite-stimulating (orexigenic) and appetite-suppressing (anorexigenic) signals synthesized in the gut, brain, microbiome and adipose tissue (AT), seems to play a pivotal role in the regulation of food intake and feeding behavior, anxiety, and depression. A dysregulation of mechanisms controlling the energy balance may result in eating disorders such as anorexia nervosa (AN) and bulimia nervosa (BN). AN is a psychiatric disease defined by chronic self-induced extreme dietary restriction leading to an extremely low body weight and adiposity. BN is defined as out-of-control binge eating, which is compensated by self-induced vomiting, fasting, or excessive exercise. Certain gut microbiota-related compounds, like bacterial chaperone protein Escherichia coli caseinolytic protease B (ClpB) and food-derived antigens were recently described to trigger the production of autoantibodies cross-reacting with appetite-regulating hormones and neurotransmitters. Gut microbiome may be a potential manipulator for AT and energy homeostasis. Thus, the regulation of appetite, emotion, mood, and nutritional status is also under the control of neuroimmunoendocrine mechanisms by secretion of autoantibodies directed against neuropeptides, neuroactive metabolites, and peptides. In AN and BN, altered cholinergic, dopaminergic, adrenergic, and serotonergic relays may lead to abnormal AT, gut, and brain hormone secretion. The present review summarizes updated knowledge regarding the gut dysbiosis, gut-barrier permeability, short-chain fatty acids (SCFA), fecal microbial transplantation (FMT), blood-brain barrier permeability, and autoantibodies within the ghrelin and melanocortin systems in eating disorders. We expect that the new knowledge may be used for the development of a novel preventive and therapeutic approach for treatment of AN and BN.
- 650 12
- $a autoprotilátky $7 D001323
- 650 _2
- $a poruchy příjmu potravy $x imunologie $x mikrobiologie $7 D001068
- 650 _2
- $a střevní mikroflóra $x imunologie $7 D000069196
- 650 _2
- $a ghrelin $x imunologie $7 D054439
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inzulin $x imunologie $7 D007328
- 650 _2
- $a leptin $x imunologie $7 D020738
- 650 _2
- $a melanocyty stimulující hormony $x imunologie $7 D009074
- 650 _2
- $a neuropeptid Y $x imunologie $7 D009478
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Prochazkova, Petra $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Roubalova, Radka $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Dvorak, Jiri $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Papezova, Hana $u Psychiatric Clinic, Eating Disorder Center, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
- 700 1_
- $a Hill, Martin $u Steroid Hormone and Proteofactors Department, Institute of Endocrinology, Prague, Czechia
- 700 1_
- $a Pokorny, Jaroslav $u First Faculty of Medicine, Institute of Physiology, Charles University, Prague, Czechia
- 700 1_
- $a Kittnar, Otomar $u First Faculty of Medicine, Institute of Physiology, Charles University, Prague, Czechia
- 700 1_
- $a Bilej, Martin $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Tlaskalova-Hogenova, Helena $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
- 773 0_
- $w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 12, č. - (2021), s. 613983
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33953692 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145229 $b ABA008
- 999 __
- $a ok $b bmc $g 1751801 $s 1155593
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 12 $c - $d 613983 $e 20210419 $i 1664-2392 $m Frontiers in endocrinology $n Front. endocrinol. $x MED00174543
- LZP __
- $a Pubmed-20220113